Status:
COMPLETED
CT Abnormalities Evocative of Lung Infection Are Associated With Lower 18F-FDG Uptake in Confirmed COVID-19 Patients
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Presence of COVID-19 Compatible CT Abnormalities
Eligibility:
All Genders
18+ years
Brief Summary
CT signs that are evocative of lung COVID-19 infections have been extensively described, whereas 18F-FDG-PET signs have not. Our current study aimed to identify specific COVID-19 18F-FDG-PET signs in ...
Eligibility Criteria
Inclusion
- Patient coming to nuclear medicine for 18F-flurodesoxyglucose (FDG) positron emission tomography computed tomography (PET-CT) with suspicion of lung involvement
- patient affiliated to a social security scheme or equivalent
- adult patient having been informed of the study
Exclusion
- patient with a negative covid 19 test
Key Trial Info
Start Date :
March 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 30 2020
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04512118
Start Date
March 15 2020
End Date
July 30 2020
Last Update
August 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU of Nancy
Vandœuvre-lès-Nancy, Grand Est, France, 54511